{"id":"https://openalex.org/W7204708024","doi":"https://doi.org/10.1016/s2152-2650(26)01862-8","title":"AML-867: Postmarketing Safety Signals of Revumenib (Menin-KMT2A Inhibitor) vs Acute Myeloid Leukemia-Targeted Therapies: A Class-Restricted Disproportionality Analysis of the FDA Adverse Event Monitoring System (2016\u20132026)","display_name":"AML-867: Postmarketing Safety Signals of Revumenib (Menin-KMT2A Inhibitor) vs Acute Myeloid Leukemia-Targeted Therapies: A Class-Restricted Disproportionality Analysis of the FDA Adverse Event Monitoring System (2016\u20132026)","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204708024","doi":"https://doi.org/10.1016/s2152-2650(26)01862-8"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(26)01862-8","doi":"https://doi.org/10.1016/s2152-2650(26)01862-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)01862-8","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5148715673","display_name":"Arashdeep Singh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800275141","display_name":"Allegheny General Hospital","ror":"https://ror.org/02gy6qp39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1310421338","https://openalex.org/I2800275141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arashdeep Singh","raw_affiliation_strings":["Allegheny General Hospital, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allegheny General Hospital, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I2800275141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102327132","display_name":"Sidharth Mahajan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133702","display_name":"MacNeal Hospital","ror":"https://ror.org/03gd8w426","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210133702"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sidharth Mahajan","raw_affiliation_strings":["Loyola MacNeal Hospital, Berwyn, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Loyola MacNeal Hospital, Berwyn, IL, USA","institution_ids":["https://openalex.org/I4210133702"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122753597","display_name":"Madho Mal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I88694374","display_name":"Marshall University","ror":"https://ror.org/02erqft81","country_code":"US","type":"education","lineage":["https://openalex.org/I88694374"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Madho Mal","raw_affiliation_strings":["Marshall University Joan C. Edwards School of Medicine, Huntington, WV, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Marshall University Joan C. Edwards School of Medicine, Huntington, WV, USA","institution_ids":["https://openalex.org/I88694374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5137275965","display_name":"Shankar Biswas","orcid":"https://orcid.org/0009-0005-2421-3953","observed_orcids":["https://orcid.org/0009-0005-2421-3953"]},"institutions":[{"id":"https://openalex.org/I1323554757","display_name":"Ivano-Frankivsk National Medical University","ror":"https://ror.org/023wxgq18","country_code":"UA","type":"education","lineage":["https://openalex.org/I1323554757"]}],"countries":["UA"],"is_corresponding":false,"raw_author_name":"Shankar Biswas","raw_affiliation_strings":["Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine","institution_ids":["https://openalex.org/I1323554757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148747484","display_name":"Bhawarpreet Bhatti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800494708","display_name":"Government Medical College, Amritsar","ror":"https://ror.org/046bk9643","country_code":"IN","type":"education","lineage":["https://openalex.org/I2800494708"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Bhawarpreet Bhatti","raw_affiliation_strings":["Government Medical College, Amritsar, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Government Medical College, Amritsar, India","institution_ids":["https://openalex.org/I2800494708"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148627042","display_name":"Gurmanleen Sohi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I101786783","display_name":"Government Medical College","ror":"https://ror.org/019e4d354","country_code":"IN","type":"education","lineage":["https://openalex.org/I101786783"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Gurmanleen Sohi","raw_affiliation_strings":["Government Medical College, Patiala, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Government Medical College, Patiala, India","institution_ids":["https://openalex.org/I101786783"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107016284","display_name":"Karanbir Singh Purewal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268885","display_name":"Dr. B.R. Ambedkar State Institute of Medical Sciences","ror":"https://ror.org/02cxg3617","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405268885"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Karanbir Purewal","raw_affiliation_strings":["Dr BR Ambedkar State Institute of Medical Sciences, Mohali, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr BR Ambedkar State Institute of Medical Sciences, Mohali, India","institution_ids":["https://openalex.org/I4405268885"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147080682","display_name":"Aniroodh Venugopalan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1323219464","display_name":"Rajarajeswari Medical College and Hospital","ror":"https://ror.org/00gn6h668","country_code":"IN","type":"education","lineage":["https://openalex.org/I1323219464"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Aniroodh Venugopalan","raw_affiliation_strings":["Rajarajeshwari Medical College and Hospital, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rajarajeshwari Medical College and Hospital, Bangalore, India","institution_ids":["https://openalex.org/I1323219464"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5148743455","display_name":"Shravani Katkam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I61631359","display_name":"Kurnool Medical College","ror":"https://ror.org/02j3bag68","country_code":"IN","type":"education","lineage":["https://openalex.org/I170558118","https://openalex.org/I61631359"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Shravani Katkam","raw_affiliation_strings":["Viswabharathi Medical College, Kurnool, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viswabharathi Medical College, Kurnool, India","institution_ids":["https://openalex.org/I61631359"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":null,"first_page":"S506","last_page":"S507"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/revumenib","display_name":"revumenib","score":0.996999979019165},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9440000057220459},{"id":"https://openalex.org/keywords/post-marketing-safety","display_name":"post-marketing safety","score":0.6859999895095825},{"id":"https://openalex.org/keywords/adverse-event-signals","display_name":"adverse event signals","score":0.6330000162124634},{"id":"https://openalex.org/keywords/disproportionality-analysis","display_name":"disproportionality analysis","score":0.8149999976158142},{"id":"https://openalex.org/keywords/differentiation-syndrome","display_name":"differentiation syndrome","score":0.8679999709129333},{"id":"https://openalex.org/keywords/qtc-prolongation","display_name":"QTc prolongation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.7929999828338623},{"id":"https://openalex.org/keywords/ziftomenib","display_name":"ziftomenib","score":0.7129999995231628},{"id":"https://openalex.org/keywords/enasidenib","display_name":"enasidenib","score":0.9169999957084656},{"id":"https://openalex.org/keywords/ivosidenib","display_name":"ivosidenib","score":0.9509999752044678},{"id":"https://openalex.org/keywords/olutasidenib","display_name":"olutasidenib","score":0.8500000238418579},{"id":"https://openalex.org/keywords/gilteritinib","display_name":"gilteritinib","score":0.9599999785423279},{"id":"https://openalex.org/keywords/midostaurin","display_name":"midostaurin","score":0.996999979019165},{"id":"https://openalex.org/keywords/quizartinib","display_name":"quizartinib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":1.0},{"id":"https://openalex.org/keywords/fda-adverse-event-reporting-system","display_name":"FDA Adverse Event Reporting System","score":0.7870000004768372}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9732999801635742},{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.7214999794960022},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5978000164031982},{"id":"https://openalex.org/C2777105317","wikidata":"https://www.wikidata.org/wiki/Q4686710","display_name":"Adverse Event Reporting System","level":3,"score":0.5640000104904175},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5026000142097473},{"id":"https://openalex.org/C2779662365","wikidata":"https://www.wikidata.org/wiki/Q5416694","display_name":"Event (particle physics)","level":2,"score":0.46950000524520874},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.4392000138759613},{"id":"https://openalex.org/C2777488183","wikidata":"https://www.wikidata.org/wiki/Q6900510","display_name":"Safety monitoring","level":2,"score":0.4032999873161316},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.33489999175071716},{"id":"https://openalex.org/C2779328685","wikidata":"https://www.wikidata.org/wiki/Q1475557","display_name":"Patient safety","level":3,"score":0.2847999930381775},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.2709999978542328},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2644999921321869},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2621999979019165},{"id":"https://openalex.org/C2778135862","wikidata":"https://www.wikidata.org/wiki/Q5416719","display_name":"Event monitoring","level":3,"score":0.258899986743927}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(26)01862-8","doi":"https://doi.org/10.1016/s2152-2650(26)01862-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)01862-8","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2026-08-31T00:00:00"}